Skip to main content

Research Repository

See what's under the surface

Advanced Search

Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer

Kurozumi, Sasagu; Joseph, Chitra; Sonbul, Sultan; Aleskandarany, Mohammed A.; Pigera, Marian; Alsaleem, Mansour; Alsaeed, Sami; Kariri, Yousif; Nolan, Christopher C.; Diez-Rodriguez, Maria; Johnston, Simon; Mongan, Nigel P.; Fujii, Takaaki; Shirabe, Ken; Martin, Stewart G.; Ellis, Ian O.; Green, Andrew R.; Rakha, Emad A.

Authors

Sasagu Kurozumi

Chitra Joseph

Sultan Sonbul

Mohammed A. Aleskandarany

Marian Pigera

Mansour Alsaleem

Sami Alsaeed

Yousif Kariri

Christopher C. Nolan

Maria Diez-Rodriguez

Simon Johnston

Nigel P. Mongan

Takaaki Fujii

Ken Shirabe

Stewart G. Martin

Andrew R. Green

Emad A. Rakha



Abstract

BACKGROUND: Ras association and pleckstrin homology domains 1 (RAPH1) is involved in cytoskeleton regulation and re-epithelialisation in invasive carcinoma and therefore may play a key role in carcinogenesis and metastasis. We herein investigated the biological and clinical significance of RAPH1 in breast cancer using large annotated cohorts.
METHODS: The clinicopathological and prognostic significance of RAPH1 was assessed at the genomic and transcriptomic levels using The Cancer Genome Atlas (TCGA) dataset (n=1039) and the results were validated using the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort (n=1980). RAPH1 protein expression was evaluated by immunohistochemistry in a large, well-characterised cohort of early-stage breast cancer (n=1040).
RESULTS: In both the TCGA-BRCA and METABRIC cohorts, RAPH1 mRNA expression and RAPH1 copy number alteration were strongly correlated. RAPH1 mRNA overexpression was significantly correlated with high expression of adhesion and EMT markers including CDH1, TGFbeta1 and CD44. RAPH1 mRNA overexpression was a significant predictor of a poor prognosis (Hazard ratio: 3.88; p = 0.049). High RAPH1 protein expression was associated with higher grade tumours with high proliferation index, triple negative phenotype and high E-cadherin expression. High RAPH1 protein expression was an independent predictor of shorter survival (Hazard ratio: 4.37; p = 0.037).
CONCLUSIONS: High RAPH1 expression is correlated with aggressive breast cancer phenotypes and provides independent prognostic value in invasive breast cancer.

Journal Article Type Article
Publication Date 2018-11
Journal Breast Cancer Research and Treatment
Print ISSN 0167-6806
Electronic ISSN 1573-7217
Publisher Humana Press
Peer Reviewed Peer Reviewed
Volume 172
Issue 1
Pages 61–68
APA6 Citation Kurozumi, S., Joseph, C., Sonbul, S., Aleskandarany, M. A., Pigera, M., Alsaleem, M., …Rakha, E. A. (2018). Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer. Breast Cancer Research and Treatment, 172(1), 61–68. doi:10.1007/s10549-018-4891-y
DOI https://doi.org/10.1007/s10549-018-4891-y
Keywords invasive breast cancer; lymphovascular invasion; ras association and pleckstrin homology domains 1; re-epithelialisation; E-cadherin
Publisher URL https://link.springer.com/article/10.1007%2Fs10549-018-4891-y
Copyright Statement Copyright information regarding this work can be found at the following address: http://eprints.nottingh.../end_user_agreement.pdf
Additional Information This is a pre-print of an article published in Breast Cancer Research and Treatment. The final authenticated version is available online at: https://doi.org/10.1007/s10549-018-4891-y

Files

Final RAPH1 BCRT manuscript.pdf (2.5 Mb)
PDF

Copyright Statement
Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf







You might also like



Downloadable Citations

;